The psychological sequelae of psoriasis: Results of a qualitative study

Psychology, Health and Medicine

Volumn 14, Issue 2, 2009, Pages 150-161

  Magin, Parker ^a   Adams, Jon ^b   Heading, Gaynor ^c   Pond, Dimity ^a   Smith, Wayne ^d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Anxiety; Depression; Mental disorders; Psoriasis

Indexed keywords

ADULT; AGED; ANXIETY; DEPRESSION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PSORIASIS; SELF CONCEPT;

EID: 61649121710     PISSN: 13548506     EISSN: None     Source Type: Journal    
DOI: 10.1080/13548500802512294     Document Type: Article

References (41)

1. Akay, A., Pekcanlar, A., Bozdag, K.E., Altintas, L., & Karaman, A. (2002). Assessment of depression in subjects with psoriasis vulgaris and lichen planus. Journal of the European Academy of Dermatology and Venereology, 16, 347-352.
2. Alahlafi, A., & Burge, S. (2005). What should undergraduate medical students know about psoriasis? Involving patients in curriculum development: modified Delphi technique. British Medical Journal, 330, 633-636.
3. Al-Suwaidan, S.N., & Feldman, S.R. (2000). Clearance is not a realistic expectation of psoriasis treatment. Journal of the American Academy of Dermatology, 42, 796-802.
4. Ashcroft, D.M., Li Wan Po, A., Williams, H.C., & Griffiths, C.E. (1998). Quality of life measures in psoriasis: a critical appraisal of their quality. Journal of Clinical Pharmacy and Therapeutics, 23(5), 391-398.
5. Devrimci-Ozguven, H., Kundakci, T.N., Kumbasar, H., & Boyvat, A. (2000). The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. Journal of the European Academy of Dermatology and Venereology, 14, 267-271.
6. Feldman, S., Behnam, S.M., Behnam, S.E., & Koo, J.Y. (2005). Involving the patient: impact of inflammatory skin disease and patient-focused care. Journal of the American Academy of Dermatology, 53, S78-S85.
7. Finzi, A., Colombo, D., Caputo, A., Andreassi, L., Chimenti, S., Vena, G., et al. (2007). Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. Journal of the European Academy of Dermatology and Venereology, 21(9), 1161-1169.
8. Fortune, D.G., Richards, H.L., Griffiths, C.E., & Main, C.J. (2005). Adversarial growth in patients undergoing treatment for psoriasis: a prospective study of the ability of patients to construe benefits from negative events. Psychology, Health and Medicine, 10, 44-56.
9. Gelfand, J.M., Weinstein, R., Porter, S.B., Neimann, A.L., Berlin, J.A., & Margolis, D.J. (2005). Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Archives of Dermatology, 141, 1537-1541.
10. Gillard, S.E., & Finlay, A.Y. (2005). Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. International Journal of Clinical Practice, 59, 1260-1267.
11. Ginsburg, I.H., & Link, B.G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20, 53-63.
12. Gupta, M.A., & Gupta, A.K. (1998). Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology, 139, 846-850.
13. Gupta, M.A., & Gupta, A.K. (2003). Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. American Journal of Clinical Dermatology, 4, 833-842.
14. Horner, D., & Asher, K. (2005). General practitioners and mental health staff sharing patient care: working model. Australasian Psychiatry, 13(2), 176-180.
15. Hughes, J.E., Barraclough, B.M., Hamblin, L.G., & White, J.E. (1983). Psychiatric symptoms in dermatology patients. British Journal of Psychiatry, 143, 51-54.
16. Jowett, S., & Ryan, T. (1985). Skin disease and handicap: an analysis of the impact of skin conditions. Social Science and Medicine, 20(4), 425-429.
17. Kent, G. (2000). Understanding the experiences of people with disfigurements: an integration of four models of social and psychological functioning. Psychology Health and Medicine, 5, 117-129.
18. Kent, G., & Keohane, S. (2001). Social anxiety and disfigurement: the moderating effects of fear of negative evaluation and past experience. British Journal of Clinical Psychology, 40, 23-34.
19. Kilic, A., Gulec, M., Gul, U., & Gulec, H. (2008). Temperament and character profile of patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 22, 537-542.
20. Koo, J. (1995). The psychosocial impact of acne: patients' perceptions. Journal of the American Academy of Dermatology, 32, S26-S30.
21. Koo, J. (1996). Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatologic Clinics, 14, 485-496.
22. Kulkarni, A.S., Balkrishnan, R., Camacho, F.T., Anderson, R.T., & Feldman, S.R. (2004). Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. Journal of Drugs in Dermatology, 3(6), 661-666.
23. Leary, M.R., Rapp, S.R., Herbst, K.C., Exum, M.L., & Feldman, S.R. (1998). Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychology, 17, 530-536.
24. Magin, P., Adams, J., Heading, G., Pond, D., & Smith, W. (2006). Psychological sequelae of acne vulgaris: results of a qualitative study. Canadian Family Physician Médecin de Famille Canadien, 52(8), 978-979.
25. Mattoo, S.K., Handa, S., Kaur, I., Gupta, N., & Malhotra, R. (2001). Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. Journal of Dermatology, 28(8), 424-432.
26. McNally, N.J., Phillips, D.R., & Williams, H.C. (1998). Focus groups in dermatology. Clinical and Experimental Dermatology, 23, 195-200.
27. Miles, M., & Huberman, A. (1994). Early steps in data analysis. Qualitative data analysis: an expanded sourcebook (2nd ed., pp. 50-74). London: Sage.
28. Perrott, S.B., Murray, A.H., Lowe, J., & Mathieson, C.M. (2000). The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiology and Behavior, 70, 567-571.
29. Picardi, A., Amerio, P., Baliva, G., Barbieri, C., Teofoli, P., Bolli, S., et al. (2004). Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Dermato-Venereologica, 18, 213-217.
30. Polenghi, M.M., Molinari, E., Gala, C., Guzzi, R., Garutti, C., & Finzi, A.F. (1994). Experience with psoriasis in a psychosomatic dermatology clinic. Acta Dermato-Venereologica. Supplementum, 186, 65-66.
31. Pope, C., Ziebland, S., & Mays, N. (2000). Analysing qualitative data. British Medical Journal, 320, 114-116.
32. Renzi, C., Picardi, A., Abeni, D., Agostini, E., Baliva, G., Pasquini, P., et al. (2002). Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Archives of Dermatology, 138(3), 337-342.
33. Richards, H.L., Fortune, D.G., Griffiths, C.E., & Main, C.J. (2001). The contribution of perceptions of stigmatisation to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11-15.
34. Russo, P.A., Ilchef, R., & Cooper, A.J. (2004). Psychiatric morbidity in psoriasis: a review. Australasian Journal of Dermatology, 45, 155-159.
35. Saez-Rodriguez, M., Noda-Cabrera, A., Alvarez-Tejera, S., Guimera-Martin-Neda, F., Dorta-Alom, S., Escoda-Garcia, M., et al. (2002). The role of psychological factors in palmoplantar pustulosis. Journal of the European Academy ofDermatology andVenereology, 16(4), 325-327.
36. Sampogna, F., Tabolli, S., & Abeni, D. (2007). The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. British Journal of Dermatology, 157(3), 508-513.
37. Schmid-Ott, G., Kunsebeck, H.-W., Jager, B., Sittig, U., Hofste, N., Ott, R., et al. (2005). Significance of stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Dermato-Venereologica, 85, 27-32.
38. Sharma, N., Koranne, R.V., & Singh, R.K. (2001). Psychiatric morbidity in psoriasis and vitiligo: a comparative study. Journal of Dermatology, 28(8), 419-423.
39. Smith, S., Bury, G., O'Leary, M., Shannon, W., Tynan, A., Staines, A., et al. (2004). The North Dublin randomized controlled trial of structured diabetes shared care. Family Practice, 21(1), 39-45.
40. Strauss, A., & Corbin, J. (1990). Basics of qualitative research: grounded theory procedures and techniques (pp. 48-56). London: Sage.
41. Wahl, A.G., & E Hanestad, B.R. (2002). The bodily suffering of living with psoriasis: in-depth interviews with 22 hospitalised patients with psoriasis. Qualitative Health Research, 250-261.